Acrivon Therapeutics, Inc. develops drugs for clinical treatment. Its unique precision medicine platform is Acrivon Predictive Precision Proteomics (AP3). AP3 is used to generate proprietary OncoSignature companion diagnostics to identify patients who will benefit from the medicine. The company was founded by Peter Blume-Jensen and Kristina Masson in 2018 and is headquartered in Watertown, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
78
Frequently Asked Questions
What is Market Cap of Acrivon Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Acrivon Therapeutics Inc market cap is $56.31M.
What is the 52-week high for Acrivon Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Acrivon Therapeutics Inc 52 week high is $10.00 as of September 10, 2025.
What is the 52-week low for Acrivon Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Acrivon Therapeutics Inc 52 week low is $1.05 as of September 10, 2025.
What is Acrivon Therapeutics Inc stock price today?
Acrivon Therapeutics Inc stock price today is $1.65.
What was Acrivon Therapeutics Inc stock price yesterday?
Acrivon Therapeutics Inc stock price yesterday was $1.79.
What is the PE ratio of Acrivon Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Acrivon Therapeutics Inc’s P/E ratio is -0.80.
What is the Price-to-Book ratio of Acrivon Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Acrivon Therapeutics Inc P/B ratio is 0.3936.
What is the 50-day moving average of Acrivon Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Acrivon Therapeutics Inc 50-day moving average is $1.33.
How many employess does Acrivon Therapeutics Inc has?